No Matches Found
No Matches Found
No Matches Found
OneSource Specialty Pharma Ltd
How has been the historical performance of OneSource Speci.?
OneSource Speci. has shown significant growth in net sales, increasing from 128.18 Cr in March 2022 to 1,444.85 Cr in March 2025, despite facing challenges in profitability, with a profit before tax of -67.07 Cr in March 2025. Total assets rose to 7,550.24 Cr, but cash flow from operating activities remained negative at -67.00 Cr.
Why is OneSource Speci. falling/rising?
As of 11-Nov, OneSource Specialty Pharma Ltd's stock price is Rs 1,740.00, down 2.84%, and has underperformed its sector and the broader market, with a 4.70% decline over the past week. The stock is trading below all key moving averages and has seen a significant drop in investor participation.
Why is OneSource Speci. falling/rising?
As of 06-October, OneSource Specialty Pharma Ltd's stock price is rising at 1,886.50, reflecting a 4.44% increase. Despite recent gains, there are concerns about declining investor participation and delivery volume, which could affect future performance.
Why is OneSource Speci. falling/rising?
As of 24-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,743.60, down 2.13%, and has declined 6.4% over the last four days. The stock is underperforming relative to the market and shows reduced investor participation, indicating a bearish trend.
Why is OneSource Speci. falling/rising?
As of 23-Sep, OneSource Specialty Pharma Ltd's stock is priced at 1,772.00, down 1.69% and underperforming against both its moving averages and the broader market, with a 3.44% decline over the past week compared to a 0.34% drop in the Sensex. The stock's delivery volume has also decreased significantly, indicating reduced investor participation.
Why is OneSource Speci. falling/rising?
As of 22-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,808.70, down 1.5% and underperforming its sector. Despite increased investor participation, the stock has declined over the past week and month, indicating challenging market conditions.
Why is OneSource Speci. falling/rising?
As of 19-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,832.50, down 1.63%, and has underperformed the sector by 1.9%. Despite a recent decline, there is increased investor interest with a 39.89% rise in delivery volume.
Why is OneSource Speci. falling/rising?
As of 18-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,862.80, up 1.18% with increased investor participation. While the stock shows upward momentum, it is underperforming compared to the benchmark Sensex over the past week and month.
Why is OneSource Speci. falling/rising?
As of 17-Sep, OneSource Specialty Pharma Ltd is priced at 1,841.00, showing a slight increase but underperforming the sector and experiencing a significant drop in delivery volume. Despite a minor uptick today, the stock's recent negative trends and reduced investor participation indicate potential challenges in sustaining momentum.
Why is OneSource Speci. falling/rising?
As of 16-Sep, OneSource Specialty Pharma Ltd's stock price is declining at 1,835.10, down 0.42%, and has underperformed its sector and the benchmark Sensex over the past week and month. Despite increased investor participation, the stock remains below several key moving averages, indicating ongoing struggles in a generally favorable market.
Why is OneSource Speci. falling/rising?
As of 15-Sep, OneSource Specialty Pharma Ltd's stock is priced at 1,842.75, down 0.98% and underperforming its sector. The stock has shown a trend reversal after two days of gains, with decreased delivery volume and a decline of 2.03% over the past month, contrasting with the Sensex's positive performance.
Why is OneSource Speci. falling/rising?
As of 12-Sep, OneSource Specialty Pharma Ltd's stock price is 1,861.00, with a recent increase of 0.67%. Despite short-term gains, the stock has underperformed compared to broader market trends and shows mixed signals in its longer-term performance.
Why is OneSource Speci. falling/rising?
As of 11-Sep, OneSource Specialty Pharma Ltd's stock price is at 1,848.60, showing a slight increase of 0.35% today despite a recent decline of 1.79% over the past week and 2.45% over the past month, indicating reduced investor interest and volatility compared to the broader market's positive performance.
Why is OneSource Speci. falling/rising?
As of 10-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,842.15, down 0.59%, and has underperformed its sector today. The stock has seen significant declines over the past week and month, with reduced investor participation indicating a lack of confidence amidst a rising broader market.
Why is OneSource Speci. falling/rising?
As of 09-Sep, OneSource Specialty Pharma Ltd's stock price is at 1,853.00, showing a slight increase but underperforming compared to the sector and broader market. The stock has declined over the past week and month, with decreased delivery volume indicating reduced investor interest.
Why is OneSource Speci. falling/rising?
As of 08-Sep, OneSource Specialty Pharma Ltd's stock price is Rs 1,833.10, down 2.47%, and has underperformed the market with a 3.82% decline over three days. The stock shows mixed signals, trading above its 200-day moving average but below shorter-term averages, amid declining trading volume and lack of investor interest.
Why is OneSource Speci. falling/rising?
As of 05-Sep, OneSource Specialty Pharma Ltd's stock price is 1,879.45, down 0.15% over the last two days, despite being above longer-term moving averages. The stock has underperformed compared to the Sensex, declining 0.86% over the past month while the benchmark remained flat.
Why is OneSource Speci. falling/rising?
As of 04-September, OneSource Specialty Pharma Ltd's stock price is 1,882.20, down 1.24% after a trend reversal. Despite a weekly gain of 1.66%, the stock has underperformed its sector and shows declining investor participation.
Why is OneSource Speci. falling/rising?
As of 03-Sep, OneSource Specialty Pharma Ltd's stock price is 1,905.85, up 0.65% over the last two days, but it has underperformed its sector by 0.59%. Despite recent gains, declining investor participation raises concerns about sustained interest.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}

